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ABSTRACT
Objectives UK statistics suggest only two- thirds of 
patients with dementia get a diagnosis recorded in primary 
care. General practitioners (GPs) report barriers to formally 
diagnosing dementia, so some patients may be known 
by GPs to have dementia but may be missing a diagnosis 
in their patient record. We aimed to produce a method 
to identify these ‘known but unlabelled’ patients with 
dementia using data from primary care patient records.
Design Retrospective case–control study using routinely 
collected primary care patient records from Clinical 
Practice Research Datalink.
Setting UK general practice.
Participants English patients aged >65 years, with a 
coded diagnosis of dementia recorded in 2000–2012 
(cases), matched 1:1 with patients with no diagnosis code 
for dementia (controls).
Interventions Eight coded and nine keyword concepts 
indicating symptoms, screening tests, referrals and care 
for dementia recorded in the 5 years before diagnosis. 
We trialled machine learning classifiers to discriminate 
between cases and controls (logistic regression, naïve 
Bayes, random forest).
Primary and secondary outcomes The outcome 
variable was dementia diagnosis code; the accuracy of 
classifiers was assessed using area under the receiver 
operating characteristic curve (AUC); the order of features 
contributing to discrimination was examined.
Results 93 426 patients were included; the median age 
was 83 years (64.8% women). Three classifiers achieved 
high discrimination and performed very similarly. AUCs 
were 0.87–0.90 with coded variables, rising to 0.90–0.94 
with keywords added. Feature prioritisation was different 
for each classifier; commonly prioritised features were 
Alzheimer’s prescription, dementia annual review, memory 
loss and dementia keywords.
Conclusions It is possible to detect patients with 
dementia who are known to GPs but unlabelled with 
a diagnostic code, with a high degree of accuracy in 
electronic primary care record data. Using keywords from 
clinic notes and letters improves accuracy compared 
with coded data alone. This approach could improve 
identification of dementia cases for record- keeping, 
service planning and delivery of good quality care.
INTRODUCTION
Dementia is a term used to describe a group 
of conditions characterised by a progressive 
decline in cognitive function and consequent 
functional limitation.1 In the UK, 1.3% of 
people live with dementia, the majority of 
whom are aged >65 years. Prevalence in all 
aged over 65s is 7.1%, rising from 1.8% in 
the 65–69 age group to more than 33% in 
the over 90s.2 The challenges of dementia 
affect individuals, their family carers, health 
and care services and systems, and society as 
a whole, and addressing them has become 
Strengths and limitations of this study
 ► Our study was representative of the UK population, 
using all patients in the Clinical Practice Research 
Datalink GOLD database who were aged >65 years 
and had a first recorded dementia diagnosis in 
2000-2012 (N=46 713).
 ► However, the data used are several years old, and 
there may have been changes in clinical practice 
since.
 ► We trialled a number of binary classifiers, but com-
bining machine learning approaches might have in-
creased the accuracy achieved.
 ► The approach was additionally strengthened by the 
addition of keywords from clinic notes and text to 
coded information.
 ► A limitation is that our model was trained on cases 
who received a dementia diagnosis code at the end 
of the study period, who may differ systematically 
from those who never received a code.
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a national and international priority due to population 
ageing. It is expected that the cost of the disease to society 
will double between 2014 and 2040, reaching £55 billion 
per year in the UK.2
The UK government has recognised the benefits of an 
early diagnosis of dementia and has made improving rates 
of diagnosis a key focus of dementia policy since 2009 
with the National Dementia Strategy 20093 and the Prime 
Minister’s Challenge on Dementia in 2012 and 2020.4 5 
While the disease is incurable, a diagnosis gives the patient 
a better chance of achieving a good quality of life while 
living with dementia.6 Individuals can plan and make 
their wishes known while they still have capacity. Services 
provided by healthcare and social care professionals may 
help people with dementia to adapt their home and iden-
tify their care needs, thus avoiding or delaying having to 
move into institutionalised care. Furthermore, diagnosis 
allows people with Alzheimer’s disease to be prescribed 
medication and non- pharmaceutical treatments to maxi-
mise their cognitive function and quality of life. These 
treatments may have a particular benefit in the early 
stages of the illness.7 8
In recognition of this, general practitioners (GPs) in the 
UK are incentivised to initiate the diagnosis of dementia 
and to keep a register of patients diagnosed with dementia 
so that they can provide care proactively.9 GPs are likely to 
be the first to recognise or be consulted about dementia 
symptoms, as 98% of the UK population is registered with 
a GP to receive primary healthcare services. If GPs suspect 
dementia, they refer the patient to a specialist memory 
assessment service where a full diagnostic screening is 
carried out. If the patient is diagnosed with dementia, 
this is communicated back to the GP who then continues 
the patient’s care. GPs are reimbursed for ensuring a 
face- to- face review for each patient with dementia every 
12 months. Data collected in GP patient records about 
dementia cases (using a prescribed set of Dementia Read 
codes) are used by local Clinical Commissioning Groups 
(CCGs) as well as national bodies such as National Health 
Service (NHS) England and Public Health England to 
monitor local and national diagnosis rates and services.10
Based on an epidemiological study conducted by the 
Medical Research Council in 1998, a prevalence of 6.6% 
was estimated in people aged >65 years.11 However, based 
on dementia registers in the UK, the observed prevalence 
was found to be 3%.11 This gap has closed substantially 
due to schemes like the National Dementia Strategy,3 12 
but coded diagnoses of dementia in GP patient records 
still only identify two- thirds of cases, compared with the 
expected prevalence,10 13 and the estimated median time 
to diagnosis being recorded from dementia onset is 3.5 
years.14 While the diagnosis rate in the UK is higher than 
in many countries (eg, Lang et al15 found an average rate 
of undetected dementia of 62% across Europe, North 
America and Asia), a third of people with dementia may 
not be receiving appropriate care.
Qualitative studies with GPs have indicated that GPs 
are sometimes reluctant to diagnose dementia16–18 and 
describe dementia as ‘a complex condition that takes 
time to diagnose’.19 GPs have reported that diagnosing 
dementia early was not particularly important and may 
in fact be harmful to some patients.19 GPs tread care-
fully when initiating and communicating a diagnosis of 
dementia to their patients, as it is a stigmatised condition 
with what seems a bleak prognosis.18 20 Some researchers 
have argued that there is not enough evidence for any 
intervention that provides a positive change in prog-
nosis or well- being for individuals with dementia, and 
therefore a drive for earlier diagnosis is not justified.21 In 
addition, as elderly patients often have multiple condi-
tions, GPs report that it is difficult to integrate multiple 
clinical guidelines22 and that ‘dementia or memory prob-
lems (are) right at the bottom of the list’.23 These find-
ings suggest that patients with undiagnosed dementia 
could fall into two groups. First are those whose memory 
loss or cognitive symptoms have not been identified by 
the GP, possibly because they do not present to the GP 
very often, or they have not communicated any memory- 
related symptoms. Second, there is likely to be a group of 
patients who are known by primary care clinicians to be 
experiencing memory problems and may even have been 
screened for dementia or referred for memory assessment, 
but who have not, for many possible reasons, received a 
diagnostic code for dementia in their GP record.16 20 24 
For these patients who are ‘known but unlabelled’, there 
may be other indicators of dementia recognition and 
diagnosis in the patient record, which could enable them 
to be detected using an algorithm that combines multiple 
indicators of the disease. Following identification, the GP 
could then decide whether ‘labelling’ these patients with 
a dementia code was appropriate.
Reviews of data- driven dementia risk prediction 
models25 26 show that the majority of work in the past has 
aimed at producing risk scores that estimate the patient’s 
risk of developing dementia at some future date. Only a 
few of these risk scores have been developed on routinely 
collected primary care data, of which a notable example 
is Walters et al.27 Automated early detection of emergent 
cases has received less attention. Few attempts have been 
made to produce models that detect dementia which is 
current but unrecognised by the GP; the only examples 
using UK primary care data (known to the authors) are 
currently Jammeh et al28 and Ford et al.29 30 Other studies 
have approached this problem manually, for example, 
Russell et al31 aimed to improve recording in dementia 
registers by a hand- searching exercise, recognising the 
need to ‘clean up dementia coding and records’. This 
successful exercise increased the identification rate for 
dementia in participating GP practices by 8.8%.
Following success in detecting unrecognised patients 
with dementia,29 in this study we aimed to identify a range 
of elements in the primary care record which would iden-
tify the second group of ‘known but unlabelled’ patients 
with dementia. A second aim was to evaluate whether the 
model could be improved by the use of keyword infor-
mation in clinic notes and letters found in the patient 
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records, rather than relying solely on information 
captured in clinical codes. Automatically detecting these 
patients may help improve the quality of data in dementia 
registers, enable ongoing care and support of individual 
patients with dementia, and give commissioning bodies 
and service planners more accurate prevalence estimates.
METHODS
Study design
A retrospective case–control study using routinely 
collected primary care patient records from England, 
reported according to RECORD (Reporting of Studies 
Conducted using Observational Routinely- collected 
health Data) guidelines.32
Data source
This study used data from the UK Clinical Practice 
Research Datalink (CPRD). It was established in 1987 
and now contains anonymised healthcare records from 
more than 7 million current patients and represents up 
to 13% of the UK population.33 34 Patients are broadly 
representative of the UK general population in terms of 
age, sex and ethnicity. CPRD includes longitudinal obser-
vational data from GP electronic health record (EHR) 
systems in primary care practices, including medical 
diagnoses, referrals to specialists and to secondary care, 
testing and interventional procedures conducted in 
primary care, lifestyle information (eg, smoking, exer-
cise) and drugs prescribed in primary care.34 Data are 
captured using a structured hierarchical vocabulary 
called Read codes; these were developed by a UK GP, Dr 
James Read, in the 1980s.35 They map to other nomen-
clatures such as International Classification of Diseases 
(ICD), Systematized Nomenclature of Medicine Clinical 
Terms (SNOMED- CT) and International Classification of 
Primary Care codes. Each Read code represents a term or 
short phrase describing a health- related concept. There 
are more than 200 000 different codes, which are sorted 
into categories (diagnoses, processes of care and medi-
cation) and subchapters.36 Each clinical entity is repre-
sented by an alphanumeric code and a Read term which 
is the plain language description. CPRD curates two 
primary care databases: one is formed of patient records 
derived from a GP patient record computer software 
called VISION (CPRD GOLD) and one is formed from 
records derived from a GP patient record computer soft-
ware called EMIS (CPRD Aurum).33 This study used only 
CPRD GOLD data.
GPs also record clinical information in free- text clinic 
notes and letters. CPRD held these clinic notes at the 
time of study data extraction and made these available 
via either keyword search or release of full text for small 
samples, following three- stage manual deidentification 
of text and approval of a protocol. Since 2013, free- text 
notes and letters have not been extracted into CPRD from 
GP practices, and historic clinic text became unavailable 
to researchers in 2016. Due to this cessation of free- text 
collection, this study used data of patients who had a first 
dementia diagnosis recorded up to the end of 2012 so 
that free text was available for the full period prior to 
their diagnosis. CPRD also offers data linkages with other 
NHS and administrative data sets, but no linked data were 
used in this study.
Study population
CPRD provided the study team with longitudinal data from 
patients with a dementia code (cases) recorded between 
2000 and 2012, as defined in a code list of dementia diag-
nostic codes (general dementia, vascular and Alzheimer’s 
dementia codes) that we developed drawing on code lists 
in Russell et al31 and Rait et al37 and reported in Ford et al29 
(online supplemental appendix 1). For data extraction 
by the CPRD team, patients were required to be 65 years 
or older, and were required to have records available for 
at least 3 years prior to a first diagnosis code recorded 
between 2000 and 2012. All patients in the CPRD GOLD 
database meeting these criteria were selected to maximise 
sample size and reduce the possibility of selection bias. 
Control patients were randomly sampled from patients 
who had no dementia codes anywhere in their record (to 
reduce the likelihood that they just had a delayed diag-
nosis); who matched cases on age, sex and general prac-
tice; and who also had a minimum of 3 years of records 
before the diagnosis date of their matched case (known 
as the ‘index date’). This resulted in a near- perfect 1:1 
match between cases and controls; a few cases did not 
receive a match. No minimum duration of follow- up after 
index date was required as we did not want to bias the 
sample towards healthier individuals or exclude those 
who moved home or went into residential care (and thus 
changed GP practice) during follow- up. Thus, patients 
could have a date of death during the study as long as this 
was after the index date. Data collection on all patients 
was limited to November 2013 as this was the date of the 
final CPRD GOLD database build which included free 
text. This resulted in 47 858 cases and 47 663 controls.
The entire coded patient record was extracted for each 
patient, including all clinical codes, from the patient’s 
earliest registration date in CPRD until the date of data 
extraction (November 2013), or the patient’s date of death 
or the date they left the practice, whichever was earlier. In 
addition, CPRD ran a search through free- text notes and 
letters for keywords for all patients (described below) in 
the 24 months before the index date. For the keyword 
search, CPRD returned structured data comprising a 
count of the keywords in each keyword group, found in 
each free- text entry in the record. The study team did not 
have access to the free text of any patient for this study.
Refining participants
To standardise the data set provided by CPRD and to opti-
mise it for the planned analysis, further refinements were 
made to the sample. From the extracted data set, cases 
without matched controls and all patients lacking 5 years 
of data before the index date were removed along with 
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their corresponding match. We removed cases for whom 
we could not find a dementia Read code within the study 
period and controls who did have a dementia code, and 
we removed these along with their matched patients. See 
figure 1 for a flowchart of final participant selection.
Feature selection
Code lists
Using an expert consensus approach, with an epidemiol-
ogist, a psychiatrist and a GP, we identified a list of eight 
potential clinical concepts which would be indicators of 
the onset of dementia, initiation of the diagnostic pathway 
for dementia, or evidence of continuing care for dementia 
and which would be captured within the Read codes. 
Our final list of eight coded concepts entered into each 
model were cognitive decline; memory loss symptoms; 
Mini- Mental State Examination (MMSE); other cogni-
tive screening tests; referral to memory clinic; referral to 
psychiatrist, neurologist or geriatrician; dementia annual 
review; and Alzheimer- specific prescription codes. Rele-
vant code lists were sought from published papers, and 
where these were not available, lists were drawn up by 
author EF and checked by author PR (online supple-
mental appendix 2). Although MMSE scores are some-
times recorded in structured data, we found a majority of 
scores were missing in our data set (56%). We decided to 
keep the model as simple as possible and therefore did 
not use MMSE scores in the analysis.
Keywords from clinic notes and letters
We consulted with 17 GPs, asking them to suggest keywords 
representing terms that they might use when considering 
that a patient might be developing dementia. From these, 
we identified nine concepts: memory (suggested by 17 
GPs), cognition (6 GPs), forgetful (14 GPs) MMSE or 
other screening test (6 GPs), confused (9 GPs), dementia 
(3 GPs), behaviour (5 GPs), family concern (6 GPs) and 
third party consultation (1 GP). We then generated a 
list of concept variations and spelling variations for each 
keyword group (online supplemental appendix 3).
Analysis
Only data from 5 years before the index date up to the 
index date for each patient were used. Each patient’s 
record was searched to find all instances of the Read 
codes referring to the eight features described above. 
If any codes were found for a feature within a patient’s 
records, a dummy variable representing that feature was 
set to ‘1’; otherwise, they were defaulted to ‘0’. Simi-
larly, if evidence of keyword was found, the dummy vari-
able for keywords was set to ‘1’. A dummy variable for 
‘any keyword’ was also included. Other studies have also 
favoured binary features to reduce the influence on the 
data of the number of times a patient visits his or her GP.28
Logistic regression, random forest and naïve Bayes 
classifiers were used as they are effective supervised 
machine learning methods for the analysis and classifi-
cation of binary data. Logistic regression uses the logit 
function to find the probability of a data point belonging 
to a (binary) group, using one or more nominal, ordinal, 
interval or ratio- level independent variables.38 The addi-
tion of the LASSO (least absolute shrinkage and selection 
operator) function selects the best predictors based on 
the residual sum of squares.39 The random forest method 
is a non- parametric machine learning method for binary 
classification. It constructs a multitude of decision trees 
that best use the predictors to determine which category 
of output each case should be in. It holds the multitude 
of decision trees constant, and the output for each indi-
vidual is the mode or mean prediction class of the indi-
vidual trees.40 Naïve Bayes classifiers are based on Bayes’ 
theorem.41 Parameter estimation for naive Bayes models 
uses the method of maximum likelihood, and all predic-
tive features are treated as contributing independently of 
each other (ie, they are naïve to each other) to predict 
which category of the outcome each case belongs to.42 
These were implemented using scikit- learn with Python 
V.3.7.1 with ‘LogisticRegression’, ‘BernoulliNB’ and 
‘RandomForestClassifer’ packages, with the seed set to 42 
for reproducibility. The data set was split into a 70% set 
Figure 1 Final participant selection.
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for training the classifiers and a 30% testing set to assess 
model accuracy.
To assess the accuracy of the models, the area under 
the receiver operating characteristic curve (AUC) was 
calculated, which plots the true positive rate against the 
false positive rate for every possible cut- off of the predic-
tive model. In addition, sensitivity and specificity values 
were calculated for model cut- offs where these values 
were equally weighted. Positive predictive values (PPVs) 
were also calculated. While the sensitivity and specificity 
are fixed parameters of the test, PPVs are conditional 
on the prevalence of the condition in the tested sample. 
Given the matched case–control design, our sample 
had a dementia prevalence of 50%, which would inflate 
PPVs artificially. We therefore separately calculated the 
PPV of the model using the estimated UK prevalence of 
dementia in people aged >65 years of 7.1%.2 This was 
achieved using the values of sensitivity and specificity 
calculated above and a hypothetical sample of 100 000 
patients where 7100 had dementia.
To assess which features contributed most to the 
models, we generated relative indices, with the most 
predictive feature weighting set at 1, and other features 
shown relative to this. This was instead of reporting the 
exact outputs from each machine learning algorithm 
(such as β weights from logistic regression) because we 
wanted models to be directly compared.
Sensitivity Analysis
For the main analysis, we did not remove any controls who 
had indicators of dementia, as we felt this was closest to a 
real- world scenario. However, using only diagnosis codes 
and not Alzheimer’s medication or dementia review 
codes as the case definition of dementia may inflate the 
performance of the model. To examine the effect of 
our case definition on results, we ran sensitivity analyses 
where control patients with any Alzheimer’s medication 
prescriptions, or dementia annual review codes were 
removed from the sample, and these two code lists were 
removed as predictors from the model.
RESULTS
Study participants
The final data set consisted of 93 426 patients with a 
median age of 83 years (range, 65–110 years). There were 
32 876 male participants (35.2%) with a median age of 81 
years (range, 65–100 years) and 60 550 female participants 
(64.8%) with a median age of 83 years (range, 65–110 
years). In all, 46 713 were cases and 46 713 were controls. 
The mean number of codes recorded per patient in the 5 
years before the index date was 614 for controls and 586 
for cases (range, 0–7281).
Number of features by case and control group
Cases had much higher rates of all chosen features, as can 
be seen in table 1. The most common coded feature in 
dementia cases was memory loss codes (46%), followed 
by dementia annual review codes (37%). Keywords were 
all common throughout cases; the most frequent were 
family concern (81%), memory (58%) and dementia 
(51%). All keywords were more common in cases than in 
controls, except for third party consultation, and family 
concern was also high in controls (51%), although not as 
high as in the cases.
Model accuracy
The eight coded clinical concepts were used to train the 
three classifiers to predict which patients’ record would 
end with a dementia diagnosis and which patients’ record 
would not. Trained models were then tested on the testing 
data set, and the accuracy of discrimination was assessed. 
Using only coded variables, the three models produced 
a high level of correct discrimination between cases and 
Table 1 Number and proportion of cases and controls who 
had each feature
Feature
No. of cases with 
feature (%)
(N=46 713)






3276 (7.01) 240 (0.51)
Cognitive screening 
test
888 (1.90) 124 (0.27)
Dementia annual 
review
17 372 (37.19) 151 (0.32)
Memory loss codes 21 282 (45.56) 1387 (2.97)
MMSE test 9574 (20.32) 600 (1.28)
Referral to memory 
assessment service
3464 (7.42) 117 (0.25)








10 044 (21.50) 203 (0.43)
Keywords
Memory 27 025 (57.85) 3815 (8.17)
Cognition 8873 (18.99) 2178 (4.66)
Forgetful 14 272 (30.55) 3397 (7.27)
MMSE or screening 
test
11 969 (25.62) 2189 (4.69)
Confused 20 530 (43.95) 5334 (11.42)
Dementia 23 935 (51.24) 2848 (6.10)
Behaviour change/
problems
5388 (11.53) 2132 (4.56)
Family concerned 37 779 (80.87) 23 718 (50.77)
Third party 
consultation
706 (1.51) 1854 (3.97)
MMSE, Mini- Mental State Examination.
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controls. The three classifiers performed very similarly, 
with AUCs of 0.87–0.90 (table 2 and figure 2).
We then added the nine keywords to the code- only 
models and found that discrimination improved up to 
an AUC of 0.94 in the logistic regression and random 
forest and 0.90 in the naïve Bayes classifier (figure 3). It 
can be seen in table 2 that the inclusion of the keywords 
increased the sensitivity of the models by around 8%, 
without any detrimental effect on specificity.
Feature weighting
The relative weighting of each feature in the different 
models, with the most predictive feature weighting set at 
1, and other features shown relative to this is shown in 
table 3, separated by models for the coded data only and 
for codes and keywords together. The table shows that 
the three different models had substantial differences 
in the weighting of the different features when using 
only keywords. The logistic regression weighted most 
highly dementia annual review codes and prescriptions 
of Alzheimer’s medication, whereas the random forest 
weighted memory loss codes the highest and the naïve 
Bayes classifier weighted referral for memory assessment 
as the most informative feature.
Looking at the combined codes and keywords, similar 
codes were most important in the three models, whereas 
the most important keyword was word memory (rated 
highest feature in the random forest model), followed by 
keywords for dementia. Interestingly, the logistic regres-
sion classifier prioritised third party consultation, the 
only feature higher in the controls than in the cases. The 
naïve Bayes classifier prioritised coded variables higher 
than all keywords.
Sensitivity analysis
We reran the models removing controls with Alzheimer’s 
medication prescriptions and dementia annual review 
codes. We also removed these two code lists as predic-
tors in the model. The overall model accuracy, measured 
by AUC, was reduced for the codes- only models (AUCs: 
logistic regression 0.83; random forest 0.83; naïve Bayes 
0.83); this reflects the high contribution these two predic-
tors made in the main models. However, in these models, 
specificity increased for all codes- only models to 0.95, 
which also resulted in higher PPVs (logistic regression 
0.61; random forest 0.61; naïve Bayes 0.60). Results for 
all performance parameters for models using both codes 
and keywords remained similar (AUCs: logistic regression 
0.93; random forest 0.93; naïve Bayes 0.89). Full results of 
the sensitivity analysis are given in online supplemental 
appendix 4.
Table 2 Discrimination of three models between cases and controls
Classifier
Codes only Codes and keywords
AUC Sensitivity Specificity
PPV at 7.1% 
prevalence AUC Sensitivity Specificity
PPV at 7.1% 
prevalence
Random forest 0.90 0.77 0.92 0.46 0.94 0.85 0.92 0.46
Logistic regression 0.90 0.76 0.93 0.49 0.94 0.84 0.93 0.51
Naïve Bayes 0.87 0.78 0.91 0.45 0.90 0.80 0.91 0.43
AUC, area under the receiver operating characteristic curve; PPV, positive predictive value.
Figure 2 ROC showing discrimination between dementia 
cases and controls by three machine learning models 
with codes only. AUC, area under the receiver operating 
characteristic curve; ROC, receiver operating characteristic.
Figure 3 ROC showing discrimination between dementia 
cases and controls by three machine learning models with 
both codes and keywords. AUC, area under the receiver 
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DISCUSSION
We produced a set of binary coded variables that could 
be combined in a statistical model and which could accu-
rately classify patients who went on to have a dementia 
diagnosis formally coded. This model could be taken 
forward to the clinic to identify ‘known but unlabelled’ 
patients with dementia in primary care, thus improving 
record- keeping, prevalence estimates and ongoing care 
for these patients. We also investigated whether adding 
in information from the clinic notes and letters to the 
model, in the form of a simple keyword extraction, could 
add further value to the approach. The addition of free- 
text keywords improved the discrimination of the model 
to an excellent AUC of 0.94, suggesting this model would 
perform well in the clinic. The improved performance 
with the addition of free- text keywords was achieved 
because of increased sensitivity of the model, with no 
loss of specificity, as has been shown in a range of other 
case- identification studies incorporating free text.43 This 
study provides evidence that hidden data in these free- 
text fields can substantially improve automated detection 
of cases, adding weight to arguments that free- text data 
are valuable for research, if acceptable privacy- preserving 
methods for data sharing (such as automated information 
extraction behind a clinical firewall) can be agreed on.44 
We tried three different machine learning approaches 
that are suitable for binary data and found all performed 
similarly, although they weighted the various features 
differently in their classifications. This is likely to be due 
to the different construction of the algorithms within 
each method, for example, random forest algorithms are 
thought to weight most highly the most common features 
in the data set, rather than features which are rarer but 
differ more substantially between the two groups. Future 
work could look at whether there is added value in 
combining the three approaches, as ensemble methods 
can sometimes outperform any of the single approaches 
alone, especially where the different methods are clearly 
prioritising different features to achieve their perfor-
mance. However, most ensemble methods have been 
trialled on multiclass rather than binary classification.45
We also chose not to clean up our control group for 
evidence of dementia medication prescribing as has 
been done in other studies,46 because we felt that doing 
so would have artificially inflated the performance of 
our models. However, in the literature, multiple case 
definitions of dementia are used in primary care EHR 
research, some of which incorporate Alzheimer’s medica-
tion prescriptions or dementia review codes. To test the 
impact of our case definition choice, we ran a sensitivity 
analysis, removing patients from the control group who 
had these codes, as well as taking the code lists out of 
models as predictors. As these two predictors had been 
highly weighted in the original models, model perfor-
mance in the codes- only models dropped when they were 
removed, although specificity increased along with PPV. 
Table 3 Relative weighting of each feature in the three classifiers













Alzheimer’s medication 0.727 0.354 0.912 0.676 0.339 0.912
Cognitive decline 0.378 0.066 0.888 0.260 0.061 0.880
Cognitive screening test 0.025 0.006 0.997 0.076 0.010 0.997
Dementia annual review 1 0.845 0.957 0.917 0.888 0.957
Memory loss codes 0.622 1 0.593 0.456 0.964 0.593
MMSE 0.344 0.187 0.729 0.199 0.157 0.729
Referral to memory assessment 0.312 0.049 1 0.143 0.033 1
Referral to psychiatrist, neurologist or 
geriatrician
0.345 0.292 0.509 0.248 0.210 0.509
Keyword dementia – – – 0.494 0.975 0.473
Keyword memory – – – 0.251 1 0.422
Keyword confusion – – – 0.238 0.444 0.363
Keyword behaviour – – – 0.037 0.091 0.520
Keyword cognition – – – 0.031 0.078 0.515
Keyword family – – – 0.158 0.079 0.113
Keyword MMSE – – – 0.019 0.119 0.515
Keyword forget – – – 0.051 0.087 0.439
Keyword third party consultation – – – 1 0.200 0.544
MMSE, Mini- Mental State Examination. by copyright.
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Interestingly, however, there was very little drop in perfor-
mance in the models that used both codes and keywords, 
suggesting the keywords could make up for the loss of 
these two sets of codes. The case definition most useful in 
practice will depend on how GPs make up the inclusion 
criteria for their dementia registers. Where GP practices 
use only dementia codes for populating their case register, 
an algorithm which searches for Alzheimer’s medication 
prescriptions or dementia annual review will be helpful 
for spotting true positive cases among their unlabelled 
patients with dementia.
Our study is a novel contribution to the literature. 
Studies have previously aimed to detect dementia that was 
unknown to primary care practitioners, by manual47–49 
and automated methods,28 using data from primary care 
records. In addition, a recent study by Aldus et al14 has 
explored rates and predictors of patients with dementia 
going undetected. However, to the authors’ knowledge, 
no prediction or early detection approaches have made 
the distinction between patients with dementia unknown 
to the GP and those known to the GP but nevertheless 
unrecorded with a formal diagnostic code. The study by 
Aldus et al gives the first indication of how many of the 
‘undiagnosed’ cohort may be ‘known but unlabelled’, 
suggesting that both unknown and known but unlabelled 
groups decline over time, but in that of patients with no 
diagnosis, around 66%–71% were not known to have 
symptoms, whereas 29%–34% had memory concerns or 
a referral noted in their patient record.14 These figures 
were based on small numbers, and it would be worth inves-
tigating this further to estimate the proportions of each 
group. Our team has also used social science methods, 
interviewing and surveying GPs and patients to under-
stand what is happening in this apparent ‘diagnosis gap’ 
for dementia in UK primary care. We suggest that this 
dual ‘data science and social science’ approach to under-
standing and using data in patient records for clinical 
decision or diagnostic support is valuable, as it exposes 
the underlying human decision- making and behaviour 
which influences how the data are created. These insights 
can be drawn on to improve clinical prediction models 
and make them more relevant for key stakeholders, which 
is likely to improve implementation. A further avenue 
for exploration with GPs, and other stakeholders such as 
service commissioners, is whether the results produced by 
this approach would be of value either for improving indi-
vidual patient care or for service and resource planning, 
or commissioning, due to more accurate prevalence rates 
in patient data.
Further work should also examine the ethics and desir-
ability of such methods in practice. Previous studies have 
highlighted a range of potential ethical issues that need 
further exploration. First, according to the principles 
of ethical screening by Wilson and Jungner,50 any kind 
of screening programme is only ethical if there is an 
accepted treatment for patients with recognised disease. 
Weatherby and Agius argue that given no treatments that 
modify disease trajectory for dementia are available and 
given the possibility of false positive results, population 
screening for dementia is ethically unjustifiable, although 
a stepwise process that becomes increasingly targeted 
might be appropriate.51 A stepwise approach to detection 
may be especially important given the low PPVs found 
when assessing our model against a population preva-
lence. Ienca et al have also argued that the use of big data 
for early detection may lead to an inflation of the false posi-
tive risk, presumably because of algorithms being applied 
indiscriminately on whole populations.52 They also draw 
attention to the need for clinicians or researchers to 
be cautious about the privacy and disclosure issues of 
personal data about dementia, as this would be a highly 
sensitive information.52 Other authors have discussed the 
ethical implications of genetic testing for Alzheimer’s 
risk in early detection or predictive models,51 53 as well as 
needing to maintain the ‘right not to know’ for patients.54 
Drawing on these debates and other literature, Thyrian 
et al argue that early recognition is wanted by a majority 
of patients if offered in primary care, that GPs are also 
largely in favour55 and that evidence- based case- finding 
algorithms may be ethically acceptable in primary care if 
tailored to both diagnostic procedures and, importantly, 
a postdiagnostic support package.56
Strength and limitations
This study used a large sample of English patients who 
were all aged >65 years, and patients registered in CPRD 
are thought to be representative of patients in England 
as a whole. However, to ensure that this model is robust 
to different patient groups, it should now be evalu-
ated in a new patient sample, perhaps in one which is 
produced from a different general practice computer 
system (CPRD GOLD data are harvested from VISION 
software). A further strength is that we specified a very 
simple model that dichotomised the presence of an 
indicator from a code list; this means the model can 
be readily operationalised in any GP record system and 
should be robust to number and order of code accrual 
in the patient record.
However, there are important limitations in our study 
design which could be assessed or addressed in future 
work. Notably, data collection was limited to cases iden-
tified before the end of 2012, and therefore it is unclear 
whether the same model would apply in current times, 
as the many government initiatives that have been 
implemented since our study’s data collection may have 
changed clinical practice and thus recording. We plan 
future work to assess this and to strengthen the anal-
ysis using a cohort design and linked data from hospital 
records and death certificate data. We used a matched 
case–control design in which the contribution of age 
and sex to the model was controlled for in the matching 
and in which only one control for each dementia case 
was used. Using more controls per case would have 
increased statistical power and reduced the risk that 
controls were in fact undiagnosed dementia cases. We 
by copyright.
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also chose not to use MMSE score, as we aimed to create 
simple models with binary predictors and because the 
majority of MMSE scores were missing from structured 
data. A future cohort study where the prevalence is 
lower, where age can be added as a predictor, where 
possible false negatives can be removed from the 
control group and which could explore more complex 
predictors such as MMSE score will be a robust assess-
ment of this model’s replicability.
A further limitation is that our model was trained on 
cases who received a dementia diagnosis code at the 
end of the study period. There are likely to be a number 
of dementia cases who never receive a dementia code, 
and it remains a possibility that these patients differ 
in systematic ways from cases who go on to receive a 
code. The ability of our model to detect patients who 
never receive a code is therefore unknown. One possi-
bility is that patients detected by our model will have 
mild cognitive impairment or another non- dementia 
memory complaint; this may especially be true given 
the low expected PPV in an unselected population of 
over 65s. An evaluation in a GP practice, where the 
predictions of the model are assessed and validated 
by the practising GP, would give us further informa-
tion about its performance in real- life clinical settings 
and would help us understand more about potential 
false positives flagged by the model. Finally, we used a 
very simple keyword extraction to access the keyword 
data and did not incorporate any natural language 
processing to identify negation, hedging, subject or 
timing of the words we identified. We may therefore 
have oversampled instances of the clinical concepts 
being recorded about the patients; however, this would 
have affected both cases and controls equally and is 
most likely to have resulted in a bias towards the null. It 
was important for our study design that we chose simple 
feature extraction methods that could potentially be 
recreated in a busy clinic.
Implications and future steps
Our model shows good accuracy in identifying patients 
with dementia who have been detected as likely to have 
dementia but who currently have no diagnostic code 
for the condition. As outlined above, two further vali-
dation studies are now indicated: first, a replication in 
a cohort study using similar primary care patient data, 
and second, a proof- of- concept trial in a local GP prac-
tice or primary care network. We hope that if these 
two further pieces of work indicate the same excellent 
discrimination between patients with dementia and 
those without, and following steps to determine the 
threshold resulting in high specificity and sensitivity, 
and identifying reasons for potential false positives, this 
model could be adopted by GPs and CCGs to improve 
the quality of their dementia registers and to aid service 
planning.
These findings also provide a potential way for EHR 
researchers to extend their dementia case identification 
when using primary care data for dementia research 
and potentially to improve research quality. Emerging 
evidence on the rates of undetected dementia14 and 
novel methods for identifying probable but unlabelled 
cases such as those reported here mean that researchers 
could run sensitivity analyses on a range of more and less 
sensitive dementia definitions, rather than rely on diag-
nosis codes alone. We suggest exploring combinations 
of memory loss symptoms, Alzheimer- specific prescrip-
tions and dementia annual review codes to extend the 
case definition of dementia in EHR research and to 
conduct validation studies on these new case identifi-
cation methods and evaluate reasons for false positives. 
MMSE scores, where recorded, could be explored as an 
additional variable of particular value. As random forest 
and logistic regression models performed very similarly 
in this and other studies,29 we would suggest either 
analytical approach could be valuable for classification 
tasks in dementia EHR research.
CONCLUSIONS
We have shown that a simple model made up of indica-
tions of dementia symptoms, screening tests, referral and 
follow- up care in coded and free- text data can identify 
primary care patients who have recognised dementia 
but no diagnostic code for it in their record. This model 
can be taken forward for further validation and used by 
GPs and commissioners to improve the quality of data on 
patients with dementia, and as a result improve dementia 
care and services.
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